{
    "Trade/Device Name(s)": [
        "iQ Body Fluids Control"
    ],
    "Submitter Information": "Streck",
    "510(k) Number": "K051706",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000076"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPK"
    ],
    "Summary Letter Date": "August 17, 2005",
    "Summary Letter Received Date": "August 11, 2005",
    "Submission Date": "August 10, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology Quality Control Mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Red blood cells",
        "Nucleated cells"
    ],
    "Specimen Type(s)": [
        "Body fluid"
    ],
    "Specimen Container(s)": [
        "Glass vial"
    ],
    "Instrument(s)/Platform(s)": [
        "iQ Series analyzers",
        "iQ Body Fluids Module"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for iQ Body Fluids Control as a stabilized human cell suspension used as a control on iQ Series analyzers with the Body Fluids Module.",
    "Indications for Use Summary": "Intended for use on iQ Series analyzers with Body Fluids Module as a control for evaluating body fluid RBC and nucleated cell counts.",
    "fda_folder": "Hematology"
}